Real-time enrollment status for this high-grade glioma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:59 PM UTC
| NCT Number | NCT06482905 |
| Recruiting Status | Recruiting |
| Condition | High-grade Glioma |
| Phase | Clinical Trial |
| Target Enrollment | 52 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Tcelltech Inc. |
| Last Updated on CT.gov | March 24, 2026 (Mar 24, 2026) |
As of July 13, 2026: Clinical trial NCT06482905 is currently recruiting participants. This clinical trial study for high-grade glioma is actively seeking new participants at 3 locations across the United States. The study is sponsored by Tcelltech Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06482905 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06482905 was last updated Mar 24, 2026 (March 24, 2026). HelloStudys verifies this status automatically.